Clinical trial
Study Comparing Two Sirolimus Regimens vs. Tacrolimus and Mycophenolate Mofetil…
NCT00266123 · Wyeth is now a wholly owned subsidiary of Pfizer, Industry · Completed
Key facts
| NCT number | NCT00266123 |
|---|---|
| Title | Study Comparing Two Sirolimus Regimens vs. Tacrolimus and Mycophenolate Mofetil Regimen in Kidney Transplant Recipients |
| Official title | A Randomized Open-Label Study to Compare the Safety and Efficacy of Two Different Sirolimus Regimens With a Tacrolimus + Mycophenolate Mofetil Regimen in De Novo Renal Allograft Recipients |
| Lead sponsor | Wyeth is now a wholly owned subsidiary of Pfizer, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Graft Rejection, Kidney Failure, Kidney Transplant |
| Intervention type | Drug |
| Interventions | Sirolimus |
| Enrollment | 420 |
| Start date | Mar 1, 2004 |
| Completion | Jul 1, 2007 |
| First posted | Dec 15, 2005 |
| Last update posted | Dec 27, 2007 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: